Lori A. Snyder - 08 Feb 2024 Form 4 Insider Report for CARLISLE COMPANIES INC (CSL)

Signature
/s/ Lori A. Snyder by Ronald P. Fuss, attorney-in-fact
Issuer symbol
CSL
Transactions as of
08 Feb 2024
Net transactions value
-$1,521,084
Form type
4
Filing time
12 Feb 2024, 14:45:10 UTC
Previous filing
05 Feb 2024
Next filing
07 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSL Common Stock Options Exercise $51,316 +472 +9.1% $108.72 5,684 08 Feb 2024 Direct
transaction CSL Common Stock Sale $159,781 -472 -8.3% $338.52 5,212 08 Feb 2024 Direct F1
transaction CSL Common Stock Options Exercise $138,155 +1,247 +24% $110.79 6,459 08 Feb 2024 Direct
transaction CSL Common Stock Sale $422,583 -1,247 -19% $338.88 5,212 08 Feb 2024 Direct F2
transaction CSL Common Stock Options Exercise $223,553 +1,385 +27% $161.41 6,597 08 Feb 2024 Direct
transaction CSL Common Stock Sale $469,986 -1,385 -21% $339.34 5,212 08 Feb 2024 Direct F3
transaction CSL Common Stock Options Exercise $390,000 +2,600 +50% $150.00 7,812 08 Feb 2024 Direct
transaction CSL Common Stock Sale $883,896 -2,600 -33% $339.96 5,212 08 Feb 2024 Direct
transaction CSL Common Stock Options Exercise $346,866 +1,560 +30% $222.35 6,772 08 Feb 2024 Direct
transaction CSL Common Stock Sale $530,338 -1,560 -23% $339.96 5,212 08 Feb 2024 Direct
transaction CSL Common Stock Options Exercise $209,970 +837 +16% $250.86 6,049 08 Feb 2024 Direct
transaction CSL Common Stock Sale $284,806 -837 -14% $340.27 5,212 08 Feb 2024 Direct F4
transaction CSL Common Stock Options Exercise $39,223 +243 +37% $161.41 898 08 Feb 2024 By spouse
transaction CSL Common Stock Sale $81,893 -243 -27% $337.01 655 08 Feb 2024 By spouse
transaction CSL Common Stock Options Exercise $51,750 +345 +53% $150.00 1,000 08 Feb 2024 By spouse
transaction CSL Common Stock Sale $116,362 -345 -34% $337.28 655 08 Feb 2024 By spouse F5
transaction CSL Common Stock Options Exercise $33,352 +150 +23% $222.35 805 08 Feb 2024 By spouse
transaction CSL Common Stock Sale $50,656 -150 -19% $337.71 655 08 Feb 2024 By spouse F6
transaction CSL Common Stock Options Exercise $14,299 +57 +8.7% $250.86 712 08 Feb 2024 By spouse
transaction CSL Common Stock Sale $19,266 -57 -8% $338.00 655 08 Feb 2024 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -472 -100% 0 08 Feb 2024 Common Stock 472 $108.72 Direct F7
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -1,247 -100% 0 08 Feb 2024 Common Stock 1,247 $110.79 Direct F7, F8
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -1,385 -100% 0 08 Feb 2024 Common Stock 1,385 $161.41 Direct F7, F9
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -2,600 -100% 0 08 Feb 2024 Common Stock 2,600 $150.00 Direct F7, F10
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -1,560 -67% 780 08 Feb 2024 Common Stock 1,560 $222.35 Direct F7, F11
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -837 -33% 1,673 08 Feb 2024 Common Stock 837 $250.86 Direct F7, F12
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -243 -100% 0 08 Feb 2024 Common Stock 243 $161.41 By spouse F7, F13
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -345 -100% 0 08 Feb 2024 Common Stock 345 $150.00 By spouse F7, F10
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -150 -67% 75 08 Feb 2024 Common Stock 150 $222.35 By spouse F7, F11
transaction CSL Employee Stock Option (Right to Buy) Options Exercise -57 -34% 113 08 Feb 2024 Common Stock 57 $250.86 By spouse F7, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $338.42 to $338.63. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F2 This transaction was executed in multiple trades at prices ranging from $338.63 to $339.07. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F3 This transaction was executed in multiple trades at prices ranging from $339.07 to $339.96. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F4 This transaction was executed in multiple trades at prices ranging from $339.96 to $340.47. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F5 This transaction was executed in multiple trades at prices ranging from $337.01 to $337.51. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F6 This transaction was executed in multiple trades at prices ranging from $337.51 to $338.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F7 The transaction is the exercise of a derivative security.
F8 The option vests in two equal annual installments beginning on February 5, 2021.
F9 The option vests in three equal annual installments beginning on February 4, 2021.
F10 The option vests in three equal annual installments beginning on February 2, 2022.
F11 The option vests in three equal annual installments beginning on February 8, 2023.
F12 The option vests in three equal annual installments beginning on January 31, 2024.
F13 The option vests in three equal annual installments beginning on February 4, 2021, of which 122 options were exercised on October 25, 2021 for which a Form 4 was inadvertently not filed previously by the reporting person.